KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Common Equity (2018 - 2025)

Progyny (PGNY) has disclosed Common Equity for 8 consecutive years, with $516.0 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 22.27% to $516.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $516.0 million through Dec 2025, up 22.27% year-over-year, with the annual reading at $516.0 million for FY2025, 22.27% up from the prior year.
  • Common Equity for Q4 2025 was $516.0 million at Progyny, down from $560.0 million in the prior quarter.
  • The five-year high for Common Equity was $571.6 million in Q1 2024, with the low at $184.6 million in Q1 2021.
  • Average Common Equity over 5 years is $404.3 million, with a median of $429.6 million recorded in 2023.
  • The sharpest move saw Common Equity soared 78.03% in 2021, then dropped 23.74% in 2024.
  • Over 5 years, Common Equity stood at $251.8 million in 2021, then soared by 49.7% to $377.0 million in 2022, then soared by 46.81% to $553.4 million in 2023, then decreased by 23.74% to $422.1 million in 2024, then increased by 22.27% to $516.0 million in 2025.
  • According to Business Quant data, Common Equity over the past three periods came in at $516.0 million, $560.0 million, and $515.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.